# VibroniX

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vibronix

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Website: www.vibronixinc.com
- Total disclosed funding: $14M
- Latest round: Series B (Sep 14, 2026)
- Investors on record: 5

## About

Based in Suzhou, China, and founded in 2017, Zhejiang Weibang Zhendian Optoelectronic Technology Co., Ltd., trading as VibroniX, is a spectral analysis instrument developer, mainly providing innovative application services of molecular vibration spectroscopy technology. The co-founders, Pu Wang, graduated from Weldon School of Biomedical Engineering at Purdue University, and Jixin Cheng, graduated from Boston University. It has cooperated with Purdue University, Massachusetts General Hospital, and ParkView Health. VibroniX has set up 2 subsidiaries, over 10 core patents, medical device quality system certification and GMP system certification. 
In September 2026, VibroniX raised a Series B funding led by Dalton Venture, with participation from IDG Capital.

VibroniX has independently developed coherent Raman technology platform, transient absorption technology platform and transient laser infrared technology platform. Its core products are LipoPAT, AcuSee, and AcouStar. The company's products can be used in life science scenarios such as tumor research, synthetic biology research and production quality control scenarios, material science scenarios such as graphene, organic optoelectronic materials, and environmental science scenarios such as environmental testing.

The company generates revenue by providing spectral analysis and imaging products and precision medical diagnostic platforms.

The Series B funding will primarily be used to advance the commercialization of products across sectors such as industrial inspection, clinical applications, and AI for Science.

## Funding rounds

- Series B, Sep 14, 2026 — IDG Capital, Dalton Venture
- Series A, Jun 24, 2024, $14M — Founder H Fund, Tao Capital, Frees Fund

## Investors

- Founder H Fund (https://capitalatlas.ai/funds/founder-h-fund) — Series A
- Tao Capital (https://capitalatlas.ai/funds/tao-capital) — Series A
- Frees Fund (https://capitalatlas.ai/funds/frees-fund) — Series A
- IDG Capital (https://capitalatlas.ai/funds/idg-capital) — Series B
- Dalton Venture (https://capitalatlas.ai/funds/dalton-venture) — Series B